Ryan Riahi is a Dermatology physician affiliated with DermSurgery Associates. OpenAlex indexes 34 publications with 561 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1415 Hwy 6 Suite C-400
Sugarland, TX 77478
Telephone
281-491-9278Provider last certified this registry record 8 Sept 2022.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202525 payments
- Arcutis Biotherapeutics, Inc.Program year202519 payments
- GENZYME CORPORATIONProgram year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
31%Azole Antifungal18.1%Ketoconazole86%Fluconazole14%Part D≥109 patientsTetracycline-class Drug6.9%Doxycycline Monohydrate89%Doxycycline Hyclate11%Part D<11 patients+ 3 more classes in this area
Sensory organs
21.1%Corticosteroid21.1%Hydrocortisone42%Clobetasol Propionate37%Betamethasone Dipropionate8%Betamethasone Diprop Augmented8%Desonide5%Part D≥83 patientsCardiovascular
11.3%Arteriolar Vasodilator10.1%Minoxidil100%Part D≥47 patientsAldosterone antagonist (MRA)1.2%Spironolactone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Genital Rejuvenation of Scrotal and Vulvar Angiokeratomas: Laser Therapy of Scrotum and Vulva Lesions.
PubMed
2021
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”